| pubmed-article:9131947 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C1708335 | lld:lifeskim |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C0117996 | lld:lifeskim |
| pubmed-article:9131947 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:9131947 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9131947 | pubmed:dateCreated | 1997-4-30 | lld:pubmed |
| pubmed-article:9131947 | pubmed:abstractText | The present study was undertaken to see whether the difference in plasma cortisol suppression between single and repeated dosing of fluticasone propionate (FP) can be explained by systemic accumulation. | lld:pubmed |
| pubmed-article:9131947 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9131947 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9131947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9131947 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9131947 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:9131947 | pubmed:issn | 0306-5251 | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:PaulsonJJ | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:KällénAA | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:WirénJ EJE | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:ThorssonLL | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:EdsbäckerSS | lld:pubmed |
| pubmed-article:9131947 | pubmed:author | pubmed-author:DahlströmKK | lld:pubmed |
| pubmed-article:9131947 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9131947 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:9131947 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9131947 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9131947 | pubmed:pagination | 155-61 | lld:pubmed |
| pubmed-article:9131947 | pubmed:dateRevised | 2009-10-2 | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:meshHeading | pubmed-meshheading:9131947-... | lld:pubmed |
| pubmed-article:9131947 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9131947 | pubmed:articleTitle | Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. | lld:pubmed |
| pubmed-article:9131947 | pubmed:affiliation | Astra Draco AB, Lund, Sweden. | lld:pubmed |
| pubmed-article:9131947 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9131947 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9131947 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9131947 | lld:pubmed |
